Research Article | Open Access
Saad B. Almasaudi, Nagla A. El-Shitany, Aymn T. Abbas, Umama A. Abdel-dayem, Soad S. Ali, Soad K. Al Jaouni, Steve Harakeh, "Antioxidant, Anti-inflammatory, and Antiulcer Potential of Manuka Honey against Gastric Ulcer in Rats", Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 3643824, 10 pages, 2016. https://doi.org/10.1155/2016/3643824
Antioxidant, Anti-inflammatory, and Antiulcer Potential of Manuka Honey against Gastric Ulcer in Rats
Gastric ulcers are among the most common diseases affecting humans. This study aimed at investigating the gastroprotective effects of manuka honey against ethanol-induced gastric ulcers in rats. The mechanism by which honey exerts its antiulcer potential was elucidated. Four groups of rats were used: control, ethanol (ulcer), omeprazole, and manuka honey. Stomachs were examined macroscopically for hemorrhagic lesions in the glandular mucosa, histopathological changes, and glycoprotein detection. The effects of oxidative stress were investigated using the following indicators: gastric mucosal nitric oxide (NO), reduced glutathione (GSH), lipid peroxide (MDA, measured as malondialdehyde) glutathione peroxidase (GPx), superoxide dismutase (SOD), and catalase. Plasma tumour necrosis factor-α, interleukin-1β, and IL-6 were also measured. Manuka honey significantly decreased the ulcer index, completely protected the mucosa from lesions, and preserved gastric mucosal glycoprotein. It significantly increased gastric mucosal levels of NO, GSH, GPx, and SOD. Manuka honey also decreased gastric mucosal MDA and plasma TNF-α, IL-1β, and IL-6 concentrations. In conclusion, manuka honey likely exerted its antiulcer, effect by keeping enzymatic (GPx and SOD) and nonenzymatic (GSH and NO) antioxidants as well as inflammatory cytokines (TNF-α, IL-1β, and IL-6) in a reduced form, inhibited lipid peroxidation (MDA), and preserved mucous glycoproteins levels.
Gastric ulcers have long been rated as one of the most common diseases affecting humans in general and young people in particular . There are several drug categories that have been used in the treatment of gastric ulcers, including proton pump inhibitors, M1-receptor blockers, and H2-receptor antagonists . There are numerous side effects associated with the drugs used in the treatment of ulcers, including arrhythmia, impotence, gynaecomastia, and hematopoietic changes. Moreover, there is a very high relapse rate (80% at 1st year and 100% in the 2nd year of treatment). Other issues include the long-term duration of the treatment period (therapy with H2-receptor antagonists for 1 year) and the incomplete eradication of ulcers. Therefore, new treatments have been sought to enhance the efficacy of current drugs or to discover potential new agents that are more effective and less expensive and have fewer health-associated side effects than those currently used .
Ethanol is a well-known damaging agent to the gastric mucosa, used in animals and clinical studies . The model of an ethanol-induced gastric ulcer is used for the evaluation of the gastroprotective activity of many new therapeutics and natural products . Ethanol results in a rush in neutrophil infiltration into the site of injury, which is essentially an acute inflammatory reaction. This is followed by a surge in the formation of reactive oxygen species (ROS), which cause oxidative bursts in the essential cellular components, including nucleic acids, lipids, and proteins . Ethanol also induces alterations in the cytokine balance responsible for inflammation in the gastric mucosa . The proinflammatory cytokine tumour necrosis factor-α (TNF-α) was found to play an important role in ethanol-induced apoptosis during gastric ulcer formation .
Manuka honey is rich with flavonoids. Flavonoids-polyphenolic compounds are a group of secondary metabolites naturally occurring in the plant kingdom, possess numerous pharmacological activities (antiinflammatory, antimicrobial and gastroprotective), and prevent gastric ulcer formation through several mechanisms, including antisecretory and antioxidant mechanisms .
Manuka honey is a unifloral honey derived from the manuka tree, Leptospermum scoparium, belonging to the family Myrtaceae in New Zealand and the Eastern region of Australia . It is a dark honey and has attracted a lot of attention, especially in regard to its antimicrobial agent, antioxidant efficacy, and potential role in wound healing [11, 12]. Compared to other honey types, manuka honey contains the highest amount of phenolic and flavonoid compounds (pinobanksin, pinocembrin, and chrysin) that have been identified with potent ROS scavenging activity [13–15].
This study aimed at investigating the gastroprotective effects of manuka honey against ethanol-induced gastric ulcers in rats using omeprazole as a control drug. In addition, the mechanism by which honey exerts its efficacy is elucidated in terms of oxidative stress measures and inflammatory cytokine production response.
2. Materials and Methods
Twenty-four, 6-week-old male albino rats weighing between 220 and 250 g were used in this study. The animals were housed in the animal facility at King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia, under a 12 h light/dark cycle at a temperature of 25°C and relative humidity ranging from 60 to 70% throughout the experiment. The animals had free access to diet and water ad libitum.
Prior to the induction of gastric ulcer, animals were fasted for 36 h to ensure an empty stomach (water was allowed). The animals were individually housed in wire mesh cages to avoid coprophagy. The use of experimental animals was conducted in strict compliance with the rules and regulations established by the Research Ethics Committee at King Abdulaziz University after obtaining their ethical approval to pursue this study.
2.2. Honey and Omeprazole
Royal Bee 20 + active manuka honey 100% (Royal Bee, New Zealand) was used in this study. Omeprazole was obtained from Sigma, USA. Powdered omeprazole and liquid honey were individually reconstituted in a 3% v/v tween 80 to prepare a 10% stock solution . Stock solutions were freshly prepared daily and used for feeding.
2.3. Induction of Ulcer
The induction of ulcer was achieved by oral administration (p.o.) of absolute ethanol at a dose of 1 mL/200 g body weight by intragastric gavage, as described elsewhere . The rats were killed, 1 h later by cervical dislocation after being anesthetized .
2.4. Treatment Groups
Animals were randomly divided into 4 groups (6 rats in each):(1)Control: rats in this group received tween 80, p.o. (3%).(2)Ethanol (ulcer): rats in this group received ethanol (1 mL/200 g body weight, p.o.) .(3)Omeprazole: rats in this group received omeprazole 7 days before induction of ulcer at a dose of 40 mg/kg, p.o. [19, 20].(4)Manuka honey: rats in this group received manuka honey 7 days before induction of ulcer at a dose of 0.1, 1.0, and 2.5 gm/kg, p.o. [21, 22].
2.5. Measurement of Body Weight Gain (BWG) and Food and Water Consumption
The body weight gain, total food pellet consumption, and water intake of the rats in both the control and the manuka honey (2.5 gm/kg) groups were recorded daily during the experiment.
2.6. Gross Examination of Gastric Mucosa
After sacrificing the animals, the stomachs were removed and washed with 0.9% saline solution to clean away the blood. This was followed by macroscopic examination of the stomach for the detection of any hemorrhagic lesions on the glandular mucosa. The length in mm of each lesion was measured to determine the mean ulcer index (UI) . The severity of mucosal lesions was scored as follows: no ulcer (0), small ulcer (1-2 mm) (1), medium ulcer (3-4 mm) (2), large ulcer (5-6 mm) (4), and huge ulcer (>6 mm) (8). The UI was determined by adding the sum of the total of the scores and dividing by the number of animals .
2.7. Histopathological Examination of Gastric Mucosa
Each freshly excised clean stomach was divided into two parts. One of the parts was used for the histopathological examination and glycoprotein determination. The other part was stored at −80°C pending biochemical analyses. For histopathological examination, tissues were fixed in a 10% buffered formalin solution. Formalin-fixed stomach sections were embedded in paraffin wax and serially sectioned (3–5 μm) for further examination. One part was stained with hematoxylin and eosin (H&E) and observed for pathological changes using ordinary light microscopy.
2.8. Mucosal Glycoprotein Detection
For mucosal glycoprotein detection, paraffin sections were stained with periodic acid Schiff (PAS) for each rat in each group and examined using ordinary light microscopy.
2.9. Biochemical Analysis
A frozen portion of the stomachs was thawed and used for the determination of antioxidant levels. For SOD determination, thawed tissues were homogenized in 2% Triton X-100 containing a 0.32 M sucrose solution. Other stomach portions were homogenized in 50 Mm potassium phosphate, pH 7.5 and 1 Mm EDTA for MDA, GSH, NO, GPx, and CAT. Plasma samples were used for TNF-α, IL-1β, and IL-6 measurements. Serum was used for glucose, triglycerides (TG), total cholesterol, HDL-cholesterol, and LDL-cholesterol measurements. Homogenized tissues were twice subjected to a sanitation procedure, with 30 s intervals at 4°C. After the sonication process, homogenized tissues were centrifuged at 4000 rpm/min for 10 min at 4°C.
2.10. Measurement of Serum Glucose, Triglycerides (TG), Total Cholesterol, HDL-Cholesterol, and LDL-Cholesterol
Serum levels of glucose, triglycerides (TG), total cholesterol, HDL-cholesterol, and LDL-cholesterol were determined using an Auto Analyser (DIMENSION VISTA 1500, SIEMENS, Germany).
2.11. Measurement of Gastric Mucosal Nitric Oxide (NO)
NO was measured using Biodiagnostic kits (Egypt) according to Tarpey et al. . Initially, nitrate was reduced to nitrite using the nitrate reductase enzyme. This was followed by an assay of the nitrite using Griess reagent at an optical density of 550 nm. Gastric mucosal NO concentration was expressed as μmol/g tissue.
2.12. Measurement of Gastric Mucosal Reduced Glutathione (GSH)
GSH was quantified using Biodiagnostic kits (Egypt), which was based on the method developed by Ellman . The gastric mucosal GSH concentration was expressed as U/g tissue.
2.13. Measurement of Gastric Mucosal Lipid Peroxide Measured as Malondialdehyde (MDA)
Gastric mucosal MDA was measured using Biodiagnostic kits (Egypt) according to Uchiyama and Mihara . The color formed was measured at an optical density of 535 nm. The gastric mucosal MDA concentration was expressed as nmol/g tissue.
2.14. Measurement of Gastric Mucosal Glutathione Peroxidase Enzyme Activity (GPx)
Gastric mucosal GPx activity was measured using Biodiagnostic kits (Egypt). GPx activity was determined by measuring the rate of NADPH oxidation at 340 nm using H2O2 as the substrate . GPx activity was expressed in U/g tissue.
2.15. Measurement of Gastric Mucosal Superoxide Dismutase Enzyme Activity (SOD)
Gastric mucosal SOD activity was measured using Biodiagnostic kits (Egypt) according to Nishikimi et al. . This assay depends on the ability of the SOD to inhibit the phenazinemethosulphate-mediated reduction of nitrobluetetrazolium dye. SOD activity was expressed in U/mg tissue.
2.16. Measurement of Gastric Mucosal Catalase Enzyme Activity (CAT)
CAT activity was measured using Biodiagnostic kits (Egypt) according to Aebi . H2O2 reacts with CAT. The test is based on the reaction of H2O2 with 3,5-dichloro-2-hydroxybenzene sulfonic acid and 4-aminophenazone, producing a colored chromophore that was measured at 510 nm. CAT activity was expressed in U/g tissue.
2.17. Measurement of Plasma Tumour Necrosis Factor-α (TNF-α), Interleukin-1β (IL-1β), and IL-6
TNF-α, IL-1β, and IL-6 levels were measured in an ELISA assay with Assaypro TNF-α, IL-1β, and IL-6 kits (30 Triad South Drive, St. Charles, MO 63304, USA) using monoclonal antibodies specific for TNF-α, IL-1β, and IL-6, respectively. Cytokine concentrations were calculated using standard purified recombinant cytokines.
2.18. Statistical Analysis
All data were presented as mean ± SD. Statistical software SPSS 20.0 was utilized. The results were statistically analyzed using a one-way analysis of variance (ANOVA) test. Statistical differences of were considered to be significant.
3.1. Effect of Manuka Honey on % Body Weight Gain (BWG) and Food and Water Consumption
Treatment of rats with manuka honey (2.5 g/kg, p.o.) for 7 days caused a nonsignificant change in % BWG (), daily food consumption (), and water intake () as compared to the control rats (Table 1).
|Data are mean ± SD ().|
3.2. Effect of Manuka Honey on Serum Glucose, Triglycerides (TG), Total Cholesterol, HDL-Cholesterol, and LDL-Cholesterol
Treatment of rats with manuka honey (2.5 g/kg, p.o.) for 7 days caused a nonsignificant change in serum glucose (), triglycerides (TG) (), total cholesterol (), HDL-cholesterol (), and LDL-cholesterol () as compared to the control rats (Table 2).
|Data are mean ± SD ().|
3.3. Effect of Manuka Honey on the Severity of Gastric Lesion (UI)
Treatment of rats with ethanol (1 mL/200 g, p.o.) caused a significant increase in the UI as compared to the controls () (Figure 1). The pretreatment with either omeprazole (40 mg/kg, p.o.) or manuka honey (2.5 g/kg, p.o.) in ethanol-injected rats significantly decreased the UI by 89% and 96%, respectively, as compared to the ethanol-injected rats () (Figure 1). However, pretreatment using lower concentrations of manuka honey (0.1 and 1.0 g/kg) resulted in no protection (Figures 2(c) and 2(d)).
3.4. Effect of Manuka Honey on the Severity of Gastric Lesion (Gross Examination)
Treatment of rats with ethanol caused severe lesions with extensive visible hemorrhagic necrosis of gastric mucosa (Figure 2(b)). Pretreatment of ethanol-injected rats with omeprazole decreased the gastric mucosal lesions as compared to ethanol-induced lesions (Figure 2(e)). Pretreatment of ethanol-injected rats with manuka honey showed no protection. On the other hand, pretreatment of ethanol-injected rats with manuka honey (2.5 g/kg) provided significant protection of the mucosa from ethanol-induced lesions (Figure 2(f)).
3.5. Effect of Manuka Honey on the Gastric Mucosal Glycoprotein Formation Detected by PAS Staining
Treatments of rats with ethanol caused a marked depletion of gastric mucosal glycoprotein (Figure 3). Pretreatment with both omeprazole and manuka honey in ethanol-injected rats preserved gastric mucosal glycoproteins (Figure 3).
3.6. Effect of Manuka Honey on the Gastric Mucosal Histopathological Changes Detected by H&E Staining
Treatments of rats with ethanol caused ulcer formation with marked maceration of gastric mucosa, necrosis, and hemorrhage. In addition, in some animals, there was coagulative necrosis of superficial mucosal layers and evidence of submucosal widening, indicating edema (Figure 4). Pretreatment of ethanol-injected rats with omeprazole resulted in mild histopathological changes as compared to ethanol-treated rats. Normal gastric glands with a focal loss of superficial mucous cells and hemorrhagic spots were observed in omeprazole rats (Figure 4). On the other hand, pretreatment of ethanol-injected rats with manuka honey resulted in complete protection against ethanol-induced histopathological changes (Figure 4).
3.7. Effect of Manuka Honey on Gastric Mucosal Nitric Oxide (NO), Reduced Glutathione (GSH), and Lipid Peroxides (MDA) Concentrations
Treatments of rats with ethanol caused a significant decrease in both gastric mucosal NO and GSH contents (50% and 41%, resp.) as compared to the control contents ( and 0.005, resp.) (Figures 5 and 6). On the other hand, treatment of rats with ethanol caused a significant increase (3.5-fold) in gastric mucosal MDA concentration as compared to the controls () (Figure 7). Pretreatment of ulcer-induced rats with both omeprazole and manuka honey significantly increased gastric mucosal NO (109% and 117%, resp.) ( and 0.002) and GSH contents (50% and 90%, resp.) ( and 0.004, resp.) (Figures 5 and 6). On the other hand, pretreatment of ulcer-induced rats with both omeprazole and manuka honey significantly decreased gastric mucosal MDA concentrations (43% and 37%, resp.) as compared to ethanol-injected rats ( and 0.017) (Figure 7).
3.8. Effect of Manuka Honey on Gastric Mucosal Glutathione Peroxidase (GPx), Superoxide Dismutase (SOD), and Catalase (CAT) Activities
The results of the enzymatic antioxidant analyses are shown in Table 3. Briefly, the activities of CAT were not affected in the different treatment regimens. Treatment of rats with ethanol caused a significant decrease in both gastric mucosal GPx (76%) and SOD activities (31%) as compared to the control rats ( and 0.015). Pretreatment of ethanol-injected rats with both omeprazole and manuka honey significantly increased gastric mucosal GPx (~7- and 8-fold, resp.) ( and 0.003) and SOD enzyme activity (64% and 67%, resp.) ( and 0.012, resp.).
|Data are mean ± SD ().|
Significant versus control ().
Significant versus omeprazole ().
3.9. Effect of Manuka Honey on Plasma Tumour Necrosis Factor Alpha (TNF-α), Interleukin-1 Beta (IL-1β), and Interleukin-6 (IL-6) Concentrations
The results of the inflammatory cytokine analysis are shown in Table 4. Treatment of rats with ethanol caused a significant increase in plasma TNF-α, IL-1β, and IL-6 levels (21%, 98%, and 82%, resp.) (, 0.000, and 0.000, resp.) as compared to the control group. Pretreatment of ethanol-injected rats with both omeprazole and manuka honey caused a significant decrease in plasma TNF-α (38% and 28%) ( and 0.000), IL-1β (49% and 50%) ( and 0.000), and IL-6 (45% and 47%) ( and 0.000) as compared to the ulcer-induced rats.
|Data are mean ± SD ().|
aSignificant versus control ().
bSignificant versus omeprazole ().
Our results are similar to previously reported results which found that 7 weeks feeding honey did not alter % BWG, food intake, total cholesterol, LDL-cholesterol, or triglyceride levels compared with rats fed a sugar-free diet . Moreover, short-term feeding honey resulted in no increase in HDL-cholesterol levels, compared either with baseline levels or with other dietary treatments [31, 32]. Also, our results are in agreement with a previous study which reported that honey supplementation in nondiabetic rats did not alter the serum concentrations of glucose .
The macroscopic and histologic results of this study demonstrated a significant gastroprotective activity of unifloral manuka honey against ethanol-induced stomach ulcer. This is consistent with previous results, which have demonstrated the gastroprotective activity of several types of honey, either unifloral or multifloral, and from different botanical origin [34, 35].
Ethanol-induced stomach ulcer causes an inflammatory response associated with increased neutrophil infiltration and hence results in disturbing the oxidant/antioxidant balance . Ethanol-induced stomach ulcer is usually associated with modulation of the NO pathway . Recently, ethanol has also been found to disturb the inflammatory/anti-inflammatory cytokine balance .
In this study, manuka honey, which is rich in flavonoids, increased the glycoprotein production in the ethanol model of gastric damage. It also preserved the gastric mucosal GSH. Both gastric mucus and GSH serve as protective molecules against gastric mucosal injury . Manuka honey may produce its gastroprotective effect via decreased lipid peroxidation product MDA. This could be because it reserved gastric mucosal GSH contents and increased the formation of gastric mucosal NO. Natural honey prevented gastric mucosal lesions induced by ethanol through the production of nonprotein sulfhydryls and endogenous NO . Manuka honey also increased the antioxidant activity of GPx and SOD enzymes. The antioxidant activity of manuka honey may be attributed to its antioxidant flavonoid content [14, 15]. Many studies have reported the antiulcerogenic properties of flavonoids [42, 43]. The antioxidant activities of flavonoids involve ROS scavenging, transition metal ion chelation, increase of enzymatic and nonenzymatic antioxidants, and reduction of lipid peroxidation . In addition, a recent study revealed that manuka honey was the most effective antioxidant and antibacterial honey compared to both acacia honey and wild carrot honey, possibly because of its high phenol content . Manuka honey has been known to exert antimicrobial function based on its abundant methylglyoxal content. Methylglyoxal on its own is a cytotoxic substance. It would seem, however, that the combination and ratio of methylglyoxal with other components in the manuka honey counteracts the methylglyoxal component from exhibiting such toxicity, because no cytotoxicity is seen in the required testing for FDA registration of manuka honey wound-care products .
The GPx activity in the gastric mucosa may be compromised due to ethanol activity, potentially causing an accumulation of hydrogen peroxide levels followed by lipid peroxidation. Thus, the protection of GPx activity in ethanol-treated animals by manuka honey may be due to the preservation of GSH activity and keeping it in a reduced form, in addition to its ability to eliminate hydrogen peroxide and lipid hydroperoxides from the gastric mucosal cell . It has been suggested that GSH plays a role in NO synthesis, either as a reducing cofactor for NO production [46, 47] or more likely by preventing the early inactivation of NO synthesis by ROS or NO itself . NO plays an important role in the control of gastric blood flow as well as in the maintenance of gastric mucosal integrity . NO decreases leukocyte adherence and stimulates gastric mucus secretions [49, 50]. Also, data obtained from both in vitro and in vivo studies suggested that NO exerts an antiapoptotic effect on rat gastrointestinal mucosal cells .
Furthermore, the manuka gastroprotective effect may be due to inhibition of TNF-α, IL-1β, and IL-6. These proinflammatory cytokines were reported to play a very important role in ethanol-induced gastric ulcer formation, as TNF-α is an important modulator of gastric mucosal apoptotic cell death .
In conclusion, manuka honey probably prevents ethanol-induced stomach ulcer by protecting the enzymatic (GPx and SOD) and nonenzymatic (GSH and NO) antioxidants, inhibiting lipid peroxidation (MDA), saving mucous glycoprotein, and reducing inflammatory cytokine (TNF-α, IL-1β, and IL-6) formation.
Conflict of Interests
The authors declare that there is no conflict of interests.
This work was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under Grant no. 503-130-1434. The authors therefore acknowledge, with thanks, DSR’s technical and financial support.
- M. C. Brucker and M. A. Faucher, “Pharmacologic management of common gastrointestinal health problems in women,” Journal of Nurse-Midwifery, vol. 42, no. 3, pp. 145–162, 1997.
- H. P. Rang, Pharmacology, Churchill Livingstone, Edinburgh, UK, 2003.
- K. R. DeVault and N. J. Talley, “Insights into the future of gastric acid suppression,” Nature Reviews Gastroenterology and Hepatology, vol. 6, no. 9, pp. 524–532, 2009.
- S.-H. Chen, Y.-C. Liang, J. C. J. Chao et al., “Protective effects of Ginkgo biloba extract on the ethanol-induced gastric ulcer in rats,” World Journal of Gastroenterology, vol. 11, no. 24, pp. 3746–3750, 2005.
- S. I. Abdelwahab, M. M. E. Taha, M. A. Abdulla et al., “Gastroprotective mechanism of Bauhinia thonningii Schum,” Journal of Ethnopharmacology, vol. 148, no. 1, pp. 277–286, 2013.
- P. Arda-Pirincci, S. Bolkent, and R. Yanardag, “The role of zinc sulfate and metallothionein in protection against ethanol-induced gastric damage in rats,” Digestive Diseases and Sciences, vol. 51, no. 12, pp. 2353–2360, 2006.
- S. W. Park, T. Y. Oh, Y. S. Kim et al., “Artemisia asiatica extracts protect against ethanol-induced injury in gastric mucosa of rats,” Journal of Gastroenterology and Hepatology, vol. 23, no. 6, pp. 976–984, 2008.
- Y. Du, W. Zhao, L. Lu et al., “Study on the antiulcer effects of Veronicastrum axillare on gastric ulcer in rats induced by ethanol based on tumor necrosis factor-α (TNF-α) and endothelin-1 (ET-1),” Asian Pacific Journal of Tropical Biomedicine, vol. 3, no. 12, pp. 925–930, 2013.
- K. S. Mota, G. E. N. Dias, M. E. F. Pinto et al., “Flavonoids with gastroprotective activity,” Molecules, vol. 14, no. 3, pp. 979–1012, 2009.
- Y. Kato, N. Umeda, A. Maeda, D. Matsumoto, N. Kitamoto, and H. Kikuzaki, “Identification of a novel glycoside, leptosin, as a chemical marker of manuka honey,” Journal of Agricultural and Food Chemistry, vol. 60, no. 13, pp. 3418–3423, 2012.
- S. Patel and S. Cichello, “Manuka honey: an emerging natural food with medicinal use,” Natural Products and Bioprospecting, vol. 3, pp. 121–128, 2013.
- P. C. Molan, “The role of honey in the management of wounds,” Journal of Wound Care, vol. 8, no. 8, pp. 415–418, 1999.
- H. A. Alzahrani, R. Alsabehi, L. Boukraâ, F. Abdellah, Y. Bellik, and B. A. Bakhotmah, “Antibacterial and antioxidant potency of floral honeys from different botanical and geographical origins,” Molecules, vol. 17, no. 9, pp. 10540–10549, 2012.
- C. W. Chan, B. J. Deadman, M. Manley-Harris, A. L. Wilkins, D. G. Alber, and E. Harry, “Analysis of the flavonoid component of bioactive New Zealand mānuka (Leptospermum scoparium) honey and the isolation, characterisation and synthesis of an unusual pyrrole,” Food Chemistry, vol. 141, no. 3, pp. 1772–1781, 2013.
- Z. Jubri, N. B. Abdul Rahim, and G. J. Aan, “Manuka honey protects middle-aged rats from oxidative damage,” Clinics, vol. 68, no. 11, pp. 1446–1454, 2013.
- N. Al-Jaber, “The relationship between antioxidant and anti-ulcer activities in saudi honey samples harvested from various regions in different seasons,” Food and Nutrition Sciences, vol. 04, no. 08, pp. 131–138, 2013.
- D. Hollander, A. Tarnawski, W. J. Krause, and H. Gergely, “Protective effect of sucralfate against alcohol-induced gastric mucosal injury in the rat. Macroscopic, histologic, ultrastructural, and functional time sequence analysis,” Gastroenterology, vol. 88, no. 1, pp. 366–374, 1985.
- S. Kwiecień, T. Brzozowski, and S. J. Konturek, “Effect of reactive oxygen species action on gastric mucosa in various models of mucosal injury,” Journal of Physiology and Pharmacology, vol. 53, no. 1, pp. 39–50, 2002.
- N. A. El-Shitany, “Mechanism of omeprazole induced-gastric protection against ethanol-induced gastric injury in rats: role of mucosal nitric oxide and apoptotic cell death,” in Proceedings of the 1st International Egyptian-Jordanian Conference on Biotechnology and Sustainable Development: Current Status and Future Scenarios, pp. 183–194, Cairo, Egypt, 2006.
- T. K. Motawi, M. A. Hamed, R. M. Hashem, M. H. Shabana, and O. R. Ahmed, “Protective and therapeutic effects of Argyreia speciosa against ethanol-induced gastric ulcer in rats,” Zeitschrift für Naturforschung C, vol. 67, no. 1-2, pp. 47–57, 2012.
- K. Gharzouli, A. Gharzouli, S. Amira, and S. Khennouf, “Prevention of ethanol-induced gastric lesions in rats by natural honey and glucose-fructose-sucrose-maltose mixture,” Pharmacological Research, vol. 39, no. 2, pp. 151–156, 1999.
- A. Bozkurt, M. Yuksel, G. Haklar, H. Kurtel, B. C. Yegen, and I. Alican, “Adenosine protects against indomethacin-induced gastric damage in rats,” Digestive Diseases and Sciences, vol. 43, no. 6, pp. 1258–1263, 1998.
- D. Das and R. K. Banerjee, “Effect of stress on the antioxidant enzymes and gastric ulceration,” Molecular and Cellular Biochemistry, vol. 125, no. 2, pp. 115–125, 1993.
- M. M. Tarpey, D. A. Wink, and M. B. Grisham, “Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 286, no. 3, pp. R431–R444, 2004.
- G. L. Ellman, “Tissue sulfhydryl groups,” Archives of Biochemistry and Biophysics, vol. 74, pp. 214–226, 1959.
- M. Uchiyama and M. Mihara, “Determination of malondialdehyde precursor in tissues by thiobarbituric acid test,” Analytical Biochemistry, vol. 86, pp. 271–278, 1979.
- D. E. Paglia and W. N. Valentine, “Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase,” The Journal of Laboratory and Clinical Medicine, vol. 70, no. 1, pp. 158–169, 1967.
- M. Nishikimi, N. Appaji Rao, and K. Yagi, “The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen,” Biochemical and Biophysical Research Communications, vol. 46, no. 2, pp. 849–854, 1972.
- H. Aebi, “Catalase in vitro,” Methods in Enzymology, vol. 105, pp. 121–126, 1984.
- L. Chepulis and N. Starkey, “The long-term effects of feeding honey compared with sucrose and a sugar-free diet on weight gain, lipid profiles, and DEXA measurements in rats,” Journal of Food Science, vol. 73, no. 1, pp. H1–H7, 2008.
- N. S. Al-Waili, “Intravenous and intrapulmonary administration of honey solution to healthy sheep: effects on blood sugar, renal and liver function tests, bonemarrow function, lipid profile and carbon tetrachloride-induced liver injury,” Journal of Medicinal Food, vol. 6, no. 3, pp. 231–247, 2003.
- L. M. Chepulis, “The effect of honey compared to sucrose, mixed sugars, and a sugar-free diet on weight gain in young rats,” Journal of Food Science, vol. 72, no. 3, pp. S224–S229, 2007.
- O. O. Erejuwa, S. A. Sulaiman, M. S. A. Wahab, K. N. S. Sirajudeen, M. S. M. Salleh, and S. Gurtu, “Glibenclamide or metformin combined with honey improves glycemic control in streptozotocin-induced diabetic rats,” International Journal of Biological Sciences, vol. 7, no. 2, pp. 244–252, 2011.
- E. A. Alagwu, R. O. Nneli, J. N. Egwurugwu, and E. E. Osim, “Gastric cytoprotection and honey intake in albino rats,” Nigerian Journal of Physiological Sciences, vol. 26, no. 1, pp. 39–42, 2011.
- K. Gharzouli, S. Amira, A. Gharzouli, and S. Khennouf, “Gastroprotective effects of honey and glucose-fructose-sucrose-maltose mixture against ethanol-, indomethacin-, and acidified aspirin-induced lesions in the rat,” Experimental and Toxicologic Pathology, vol. 54, no. 3, pp. 217–221, 2002.
- S. Szabo, J. S. Trier, and P. W. Frankel, “Sulfhydryl compounds may mediate gastric cytoprotection,” Science, vol. 214, no. 4517, pp. 200–202, 1981.
- B. J. R. Whittle and J. Lopez-Belmonte, “Gastric mucosal damage and protection: involvement of novel endothelium-derived mediators,” in The Stomach, W. Domschke and S. J. Konturek, Eds., pp. 68–82, Springer, Berlin, Germany, 1993.
- M. Hajrezaie, S. Golbabapour, P. Hassandarvish et al., “Acute toxicity and gastroprotection studies of a new schiff base derived copper (II) complex against ethanol-induced acute gastric lesions in rats,” PLoS ONE, vol. 7, no. 12, Article ID e51537, 2012.
- K. A. Ketuly, A. H. A. Hadi, S. Golbabapour et al., “Acute toxicity and gastroprotection studies with a newly synthesized steroid,” PLoS ONE, vol. 8, no. 3, Article ID e59296, 9 pages, 2013.
- H. M. A. Sidahmed, S. I. Abdelwahab, S. Mohan et al., “α-Mangostin from cratoxylum arborescens (Vahl) blume demonstrates anti-ulcerogenic property: a mechanistic study,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 450840, 10 pages, 2013.
- N. H. P. Cnubben, I. M. C. M. Rietjens, H. Wortelboer, J. P. J. Van Zanden, and P. J. Van Bladeren, “The interplay of glutathione-related processes in antioxidant defense,” Environmental Toxicology and Pharmacology, vol. 10, no. 4, pp. 141–152, 2001.
- F. G. Gonzalez and L. C. Di Stasi, “Anti-ulcerogenic and analgesic activities of the leaves of Wilbrandia ebracteata in mice,” Phytomedicine, vol. 9, no. 2, pp. 125–134, 2002.
- Ö. Coşkun, M. Kanter, F. Armutçu, K. Çetin, B. Kaybolmaz, and Ö. Yazgan, “Protective effects of quercetin, a flavonoid antioxidant, in absolute ethanol-induced acute gastric ulcer,” European Journal of General Medicine, vol. 1, no. 3, pp. 37–42, 2004.
- P. Molan and T. Rhodes, “Honey: a biologic wound dressing,” Wounds, vol. 27, no. 6, pp. 141–151, 2015.
- W. A. Gunzler and L. Flohe, “Glutathione peroxidase,” in CRC Handbook of Methods for Oxygen Radical Research, R. A. Greenwal, Ed., pp. 285–290, CRC Press, Boca Raton, Fla, USA, 1985.
- T. Mizui, H. Sato, F. Hirose, and M. Doteuchi, “Effect of antiperoxidative drugs on gastric damage induced by ethanol in rats,” Life Sciences, vol. 41, no. 6, pp. 755–763, 1987.
- J. S. Stamler, D. J. Singel, and J. Loscalzo, “Biochemistry of nitric oxide and its redox-activated forms,” Science, vol. 258, no. 5090, pp. 1898–1902, 1992.
- J. M. Griscavage, J. M. Fukuto, Y. Komori, and L. J. Ignarro, “Nitricoxide inhibits neuronal nitric oxide synthase by interacting with the heme prosthetic group. Role of tetrahydrobiopterinin modulating the inhibitory action of nitric oxide,” The Journal of Biological Chemistry, vol. 269, pp. 21644–21649, 1994.
- J. F. Brown, A. C. Keates, P. J. Hanson, and B. J. R. Whittle, “Nitric oxide generators and cGMP stimulate mucus secretion by rat gastric mucosal cells,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 265, no. 3, pp. G418–G422, 1993.
- J. L. Wallace, B. Reuter, C. Cicala, W. McKnight, M. B. Grisham, and G. Cirino, “Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat,” Gastroenterology, vol. 107, no. 1, pp. 173–179, 1994.
- R. I. Bersimbaev, Y. E. Yugai, P. J. Hanson, and I. G. Tzoy, “Effect of nitric oxide on apoptotic activity in the rat gastrointestinal tract,” European Journal of Pharmacology, vol. 423, no. 1, pp. 9–16, 2001.
Copyright © 2016 Saad B. Almasaudi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.